Delivery Order SPE2DB22D1202-SPE2DB23FHZA3
Award Date 8/21/23
Potential Completion Date 8/22/23
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $5,000 to Amerisourcebergen Drug Corporation for the supply of 100 mg/0.5 ml auto-injectors of XYOSTED. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is September 28-29, 2023. This delivery order was issued against an existing DLA contract vehicle to support the procurement of pharmaceutical products for DOD and related...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 100 mg/0.5 mL XYOSTED auto-injectors. The $1,309.95 order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of January 16, 2024. This delivery order was placed under an existing indefinite delivery contract between AmerisourceBergen Drug Corp and DLA to...
- The Defense Logistics Agency awarded a $251,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED. The single award was made against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DOD and other federal customers. Amerisourcebergen will deliver the auto-injectors from its facility in Conshohocken, Pennsylvania by mid-August to support the Department of Defense's medical readiness and...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $872.76 to Amerisourcebergen Drug Corporation for the supply of 100mg/0.5ml auto-injectors of XYOSTED. Place of performance will be in Conshohocken, Pennsylvania over the period of August 30th through 31st, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, the prime contractor performing under this contract. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $251,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 75 mg/0.5 ml auto-injectors of XYOSTED. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the DLA's pharmaceutical procurement programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 10-11, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,508 to Amerisourcebergen Drug Corporation for 100 mg/0.5 ml auto-injectors of XYOSTED. Performance will occur in Conshohocken, Pennsylvania under a contract scheduled from August 28 through 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order from its corporate office division. No set aside designation or subcontractors...
- The Defense Logistics Agency Troop Support Medical awarded a $754.26 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the provision of 100 MG/0.5 ML auto-injectors of XYOSTED. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning July 11, 2023 through July 12, 2023. No set aside designation or subcontracting details were provided. The Defense...
- The Defense Logistics Agency awarded a $502,860 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561306942 XYOSTED 75 MG/0.5 ML auto-injectors. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of 0.5ml auto-injectors to a location in Conshohocken, Pennsylvania by June 21, 2023 in support of the Department of Defense's medical supply needs. Amerisourcebergen will perform as the...
- The Defense Logistics Agency awarded a $251,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 75 mg/0.5 ml auto-injectors of XYOSTED. The single award was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the DLA's medical materiel needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 5-6, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $754.26 firm fixed price delivery order to Amerisourcebergen Drug Corporation for XYOSTED 75 MG/0.5 ML auto-injectors. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical products to a location in Conshohocken, Pennsylvania by August 3, 2023 to support Defense Logistics Agency requirements. The parent company, Amerisourcebergen Corporation, will perform the contract through its Amerisourcebergen Division. No...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FHZA3Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $4,539.12 to Amerisourcebergen Drug Corporation for the supply of 75 mg/0.5 ml auto-injectors of XYOSTED. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning August 21-22, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set aside designations were indicated. This order is likely placed against the DLA's Pharmaceutical Prime Vendor contract vehicle to support the medical readiness of DOD personnel.
Generated 12/14/23, 7:56 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 8/21/23 |